Immunopathogenesis of multiple sclerosis: concepts and controversies

Hundred and fifty years after the discovery of multiple sclerosis (MS), neither the etiology nor the mechanism of disease is fully charted, and current treatment has only modest effect. The conceptual understanding of MS rests on the animal model experimental autoimmune encephalomyelitis (EAE). Based on 70 years experience with EAE, it is widely believed that MS is an inflammatory attack on myelin and neurons orchestrated by myelin specific T cells. However, evidence supporting a key role for myelin specific T cells in MS is weak, the model fails to explain how immune self‐tolerance is broken, and the peculiar B cell response of MS is poorly reflected in EAE. The pathogenesis of MS should therefore be studied in tissue samples and cells from MS patients, as close to the diseased organ as possible. Studies on lymphocytes from CSF of MS patients suggest that viral infections may be involved in T cell activation, and that intrinsic collaboration between T and B cells could sustain the immune response. These observations could explain the perpetuating immune response in MS in the absence of an overt antigen.

[1]  G. Krishnamoorthy,et al.  Spontaneous opticospinal encephalomyelitis in a double-transgenic mouse model of autoimmune T cell/B cell cooperation. , 2006, The Journal of clinical investigation.

[2]  E. Kabat,et al.  AN ELECTROPHORETIC STUDY OF THE PROTEIN COMPONENTS IN CEREBROSPINAL FLUID AND THEIR RELATIONSHIP TO THE SERUM PROTEINS. , 1942, The Journal of clinical investigation.

[3]  P. Mcgeer,et al.  Immunologic reactions in amyotrophic lateral sclerosis brain and spinal cord tissue. , 1992, The American journal of pathology.

[4]  Frederik Barkhof,et al.  Grey matter pathology in multiple sclerosis , 2008, The Lancet Neurology.

[5]  Arne Svejgaard,et al.  A functional and structural basis for TCR cross-reactivity in multiple sclerosis , 2002, Nature Immunology.

[6]  H. Weiner,et al.  T-cell recognition of an immuno-dominant myelin basic protein epitope in multiple sclerosis , 1990, Nature.

[7]  T. Holmøy,et al.  T cells from multiple sclerosis patients recognize immunoglobulin G from cerebrospinal fluid , 2003, Multiple sclerosis.

[8]  Y. Qin,et al.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis. , 1998, The Journal of clinical investigation.

[9]  H. Waldmann,et al.  The window of therapeutic opportunity in multiple sclerosis , 2005, Journal of Neurology.

[10]  S. Ludwin,et al.  The Pathogenesis of Multiple Sclerosis: Relating Human Pathology to Experimental Studies , 2006, Journal of neuropathology and experimental neurology.

[11]  J. Geurts,et al.  Grey matter pathology in multiple sclerosis , 2006, Acta neurologica Scandinavica. Supplementum.

[12]  Hans Lassmann,et al.  Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. , 2006, Brain : a journal of neurology.

[13]  M. Barnett,et al.  Relapsing and remitting multiple sclerosis: Pathology of the newly forming lesion , 2004, Annals of neurology.

[14]  Lawrence Steinman,et al.  How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis , 2006, Annals of neurology.

[15]  T. Holmøy,et al.  Cerebrospinal fluid T cell clones from patients with multiple sclerosis: recognition of idiotopes on monoclonal IgG secreted by autologous cerebrospinal fluid B cells , 2005, European journal of immunology.

[16]  A. Compston.  The basis for treatment in multiple sclerosis , 2006, Acta neurologica Scandinavica. Supplementum.

[17]  B. Bogen,et al.  Idiotope‐specific T cell clones that recognize syngeneic immunoglobulin fragments in the context of class II molecules , 1986, European journal of immunology.

[18]  E. Norrby,et al.  Viral and bacterial antibody responses in multiple sclerosis , 1980, Annals of neurology.

[19]  C. Poser.  The multiple sclerosis trait and the development of multiple sclerosis: Genetic vulnerability and environmental effect , 2006, Clinical Neurology and Neurosurgery.

[20]  E. Thorsby,et al.  HLA associated genetic predisposition to autoimmune diseases: Genes involved and possible mechanisms. , 2005, Transplant immunology.

[21]  T. Holmøy,et al.  ALS: Cytokine profile in cerebrospinal fluid T‐cell clones , 2006, Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases.

[22]  E. Norrby,et al.  Oligoclonal IgG antibody response in the central nervous system to different measles virus antigens in subacute sclerosing panencephalitis. , 1973, Proceedings of the National Academy of Sciences of the United States of America.

[23]  C. Poser.  The pathogenesis of multiple sclerosis , 1993, Journal of the Neurological Sciences.

[24]  B. Bogen,et al.  Systemic Autoimmune Disease Caused by Autoreactive B Cells That Receive Chronic Help from Ig V Region-Specific T Cells1 , 2005, The Journal of Immunology.

[25]  J. Frank,et al.  Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand , 2000, Nature Medicine.

[26]  J. Parisi,et al.  Heterogeneity of multiple sclerosis lesions: Implications for the pathogenesis of demyelination , 2000, Annals of neurology.

[27]  Roberto Mutani,et al.  Grey Matter Pathology in Multiple Sclerosis , 2005, Journal of neuropathology and experimental neurology.

[28]  J. Strominger,et al.  Molecular mimicry in T cell-mediated autoimmunity: Viral peptides activate human T cell clones specific for myelin basic protein , 1995, Cell.

[29]  G. Cutter,et al.  Infectious causes of multiple sclerosis , 2006, The Lancet Neurology.

[30]  T. Rivers,et al.  OBSERVATIONS ON ATTEMPTS TO PRODUCE ACUTE DISSEMINATED ENCEPHALOMYELITIS IN MONKEYS , 1933, The Journal of experimental medicine.

[31]  Subramaniam Sriram,et al.  Experimental allergic encephalomyelitis: A misleading model of multiple sclerosis , 2005, Annals of neurology.